Search

everythinglearnresearchcommunity

for

Search:↓

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

A hair transplant using hair from the back of the head and pubic area was successful in creating a feminine hairline for a male-to-female transgender person.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that facial feminization surgery improves psychological well-being and social acceptance for transgender individuals.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Men and women have different hairline restoration needs, with natural design being more complex for women, and hairline changes being important for transgender individuals' transitions.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

U.S. dermatology residents need more education and experience with LGBT patients to improve their cultural competency.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

The conclusion is that certain surgeries can help people with gender dysphoria look more like their true gender and feel better.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.